3-Pyridinecarboxamide, N-(3,6-dimethyl-9H-thioxanthen-9-yl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-

Request For Quotation
3-Pyridinecarboxamide, N-(3,6-dimethyl-9H-thioxanthen-9-yl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)- Basic information
Product Name:3-Pyridinecarboxamide, N-(3,6-dimethyl-9H-thioxanthen-9-yl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-
Synonyms:3-Pyridinecarboxamide, N-(3,6-dimethyl-9H-thioxanthen-9-yl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-;HSD17B13-IN-9
CAS:2576690-78-1
MF:C22H17F3N2O2S
MW:430.44
EINECS:
Product Categories:
Mol File:2576690-78-1.mol
3-Pyridinecarboxamide, N-(3,6-dimethyl-9H-thioxanthen-9-yl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)- Structure
3-Pyridinecarboxamide, N-(3,6-dimethyl-9H-thioxanthen-9-yl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)- Chemical Properties
Boiling point 619.7±55.0 °C(Predicted)
density 1.43±0.1 g/cm3(Predicted)
pka6.23±0.10(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
3-Pyridinecarboxamide, N-(3,6-dimethyl-9H-thioxanthen-9-yl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)- Usage And Synthesis
UsesHSD17B13-IN-9 (252) is a 17β-Hydroxysteroid dehydrogenases (HSD17B13) inhibitor, with an IC50 of 0.01 μM for 50 nM HSD17B13. Used in NAFLD (Nonalcoholic fatty liver diseases) research[1].
References[1] Joseph Vacca, et al. Modulators of hsd17b13 and methods of use thereof. Patent WO2021003295.
3-Pyridinecarboxamide, N-(3,6-dimethyl-9H-thioxanthen-9-yl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)- Preparation Products And Raw materials
Tag:3-Pyridinecarboxamide, N-(3,6-dimethyl-9H-thioxanthen-9-yl)-1,2-dihydro-2-oxo-6-(trifluoromethyl)-(2576690-78-1) Related Product Information
2-Thiophenecarboxamide, 3-[(3-chloro-4-hydroxybenzoyl)amino]-N-[2-(2-methoxyphenyl)ethyl]- 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulphonyl)benzoic acid FXRHSD17B13 modulator 1 3-((4-(TrifluoroMethyl)phenyl)aMino)benzoic acid Phosphinic acid, P,P-bis(1-aziridinyl)-, (1S)-1-[3-[3-[(dimethylamino)carbonyl]phenoxy]-4-nitrophenyl]ethyl ester Linustedastatum